Sio Gene Therapies Odds of Future Stock Price Finishing Under 0.4
SIOXDelisted Stock | USD 0.40 0.01 2.56% |
Sio |
Sio Gene Target Price Odds to finish below 0.4
The tendency of Sio Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current Price | Horizon | Target Price | Odds to move below current price in 90 days |
0.40 | 90 days | 0.40 | nearly 4.26 |
Based on a normal probability distribution, the odds of Sio Gene to move below current price in 90 days from now is nearly 4.26 (This Sio Gene Therapies probability density function shows the probability of Sio Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Sio Gene has a beta of 0.18. This usually implies as returns on the market go up, Sio Gene average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Sio Gene Therapies will be expected to be much smaller as well. Additionally Sio Gene Therapies has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Sio Gene Price Density |
Price |
Predictive Modules for Sio Gene
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sio Gene Therapies. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sio Gene Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Sio Gene is not an exception. The market had few large corrections towards the Sio Gene's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Sio Gene Therapies, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Sio Gene within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.12 | |
β | Beta against Dow Jones | 0.18 | |
σ | Overall volatility | 0.02 | |
Ir | Information ratio | -0.12 |
Sio Gene Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Sio Gene for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Sio Gene Therapies can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.Sio Gene Therapies is not yet fully synchronised with the market data | |
Sio Gene Therapies has some characteristics of a very speculative penny stock | |
Sio Gene Therapies has a very high chance of going through financial distress in the upcoming years | |
Net Loss for the year was (71.89 M) with profit before overhead, payroll, taxes, and interest of 0. | |
Sio Gene Therapies currently holds about 54.77 M in cash with (60.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.74, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
Roughly 25.0% of the company outstanding shares are owned by corporate insiders |
Sio Gene Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Sio Stock often depends not only on the future outlook of the current and potential Sio Gene's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sio Gene's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 73.2 M | |
Cash And Short Term Investments | 63.7 M |
Sio Gene Technical Analysis
Sio Gene's future price can be derived by breaking down and analyzing its technical indicators over time. Sio Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Sio Gene Therapies. In general, you should focus on analyzing Sio Stock price patterns and their correlations with different microeconomic environments and drivers.
Sio Gene Predictive Forecast Models
Sio Gene's time-series forecasting models is one of many Sio Gene's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Sio Gene's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Sio Gene Therapies
Checking the ongoing alerts about Sio Gene for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Sio Gene Therapies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Sio Gene Therapies is not yet fully synchronised with the market data | |
Sio Gene Therapies has some characteristics of a very speculative penny stock | |
Sio Gene Therapies has a very high chance of going through financial distress in the upcoming years | |
Net Loss for the year was (71.89 M) with profit before overhead, payroll, taxes, and interest of 0. | |
Sio Gene Therapies currently holds about 54.77 M in cash with (60.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.74, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
Roughly 25.0% of the company outstanding shares are owned by corporate insiders |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in Sio Stock
If you are still planning to invest in Sio Gene Therapies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sio Gene's history and understand the potential risks before investing.
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |